Now as I have explained to the oaks the Covid PCR tests are complete and utter garbage. Its these fake test ( and fake covid deaths) that have been used to drive the fear, the lockdowns, masks etc and get people to take the deadly "Vaccinations" .
NOW please note this section of the article:
CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses.
MEANING: when the PCR test picks up Influenza A or B or any flu strain they currently call it a Covid positive result. Hence oaks the findings of those 7 USA Universities testing 1,500 Covid positive tests and finding only influenza A and B.
Reacall also nowhere anywhere in the world has the Covid virus ever been isolated.
The CDC and those who have pedaled the Covid hoaxes face a huge problem. The fake PCR tests so needed to drive the Plandemic are now destroying the nonsense that these deadly vaccines work.(recall Senator Ron Johnston saying 84% of people in Israel have been vaccinated and 84% of covid positives are from vaccinated people.
This is not strange as everybody above 12 years of age has had the flu and a fragment of Influenza could be detected by the test.
That oaks is why the inventor of he PCR test says it cant be used to detect Covid if it exists
Here is the article:
Audience: Individuals Performing COVID-19 Testing
Level: Laboratory Alert
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. (NOTE THE ONLY(
CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
Visit the FDA website for a list of authorized COVID-19 diagnostic methods. For a summary of the performance of FDA-authorized molecular methods with an FDA reference panel, visit this page.
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test.
CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.